Distinct types of tumor-initiating cells form human colon cancer tumors and metastases

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Sebastian M. Dieter - , German Cancer Research Center (DKFZ) (Author)
  • Claudia R. Ball - , German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg (Author)
  • Christopher M. Hoffmann - , German Cancer Research Center (DKFZ) (Author)
  • Ali Nowrouzi - , German Cancer Research Center (DKFZ) (Author)
  • Friederike Herbst - , German Cancer Research Center (DKFZ) (Author)
  • Oksana Zavidij - , German Cancer Research Center (DKFZ) (Author)
  • Ulrich Abel - , German Cancer Research Center (DKFZ), Heidelberg University  (Author)
  • Anne Arens - , German Cancer Research Center (DKFZ) (Author)
  • Wilko Weichert - , Heidelberg University  (Author)
  • Karsten Brand - , Heidelberg University  (Author)
  • Moritz Koch - , Heidelberg University  (Author)
  • Jürgen Weitz - , Heidelberg University  (Author)
  • Manfred Schmidt - , German Cancer Research Center (DKFZ) (Author)
  • Christof Von Kalle - , German Cancer Research Center (DKFZ) (Author)
  • Hanno Glimm - , German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg (Author)

Abstract

Human colon cancer harbors a small subfraction of tumor-initiating cells (TICs) that is assumed to be a functionally homogeneous stem-cell-like population driving tumor maintenance and metastasis formation. We found unexpected cellular heterogeneity within the TIC compartment, which contains three types of TICs. Extensively self-renewing long-term TICs (LT-TICs) maintained tumor formation in serial xenotransplants. Tumor transient amplifying cells (T-TACs) with limited or no self-renewal capacity contributed to tumor formation only in primary mice. Rare delayed contributing TICs (DC-TICs) were exclusively active in secondary or tertiary mice. Bone marrow was identified as an important reservoir of LT-TICs. Metastasis formation was almost exclusively driven by self-renewing LT-TICs. Our results demonstrate that tumor initiation, self-renewal, and metastasis formation are limited to particular subpopulations of TICs in primary human colon cancer. We identify LT-TICs as a quantifiable target for therapies aimed toward eradication of self-renewing tumorigenic and metastatic colon cancer cells.

Details

Original languageEnglish
Pages (from-to)357-365
Number of pages9
JournalCell Stem Cell
Volume9
Issue number4
Publication statusPublished - 4 Oct 2011
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 21982235

Keywords

Sustainable Development Goals